Acute Denervation Revealed by Electromyography, in Conjunction With Normal Appearing Lumbar Spinal Cord in NMOSD : Case Report
Fuente:
Wiley Open Access
Saved in:
| Main Authors: | Stefania Kalampokini, Effrosyni Koutsouraki, Paschalis Devranis, Martha Spilioti, Maria Moschou, Konstantinos Notas, Vasilios K. Kimiskidis |
|---|---|
| Format: | Artículo Open Access |
| Published: |
Wiley
2025
|
| Subjects: | |
| Online Access: | |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
NMOSD Revisited
by: Izumi Kawachi
Published: (2025)
by: Izumi Kawachi
Published: (2025)
NMOSD: Innate Immunology Revisited
by: Fumihiro Yanagimura, et al.
Published: (2025)
by: Fumihiro Yanagimura, et al.
Published: (2025)
A Case of AQP4 Antibody–Positive NMOSD Initially Manifesting as Extensive, Asymptomatic Cerebral White Matter Lesions and Subsequently Developing Cognitive Impairment
by: Takafumi Hosokawa, et al.
Published: (2025)
by: Takafumi Hosokawa, et al.
Published: (2025)
Profound Cognitive Impairment as a Salient Feature of Multiple Sclerosis: A Case Report
by: Shota Ito, et al.
Published: (2026)
by: Shota Ito, et al.
Published: (2026)
Effect of Disease‐Modifying Treatments in Japanese Patients With Multiple Sclerosis During the Coronavirus Disease 2019 Pandemic
by: Taisuke Ogawa, et al.
Published: (2025)
by: Taisuke Ogawa, et al.
Published: (2025)
Reconsidering Obinutuzumab: A Review of Type II Anti‐ CD20 Antibodies in Immunological Disorders of the Nervous System
by: Naif Alsaber, et al.
Published: (2025)
by: Naif Alsaber, et al.
Published: (2025)
The Japan Neuromyelitis Optica Spectrum Disorders/Myelin Oligodendrocyte Glycoprotein Antibody–Associated Disease Registry
by: Hideyuki Takeuchi, et al.
Published: (2025)
by: Hideyuki Takeuchi, et al.
Published: (2025)
Autoimmune nodopathy
by: Masahiro Iijima
Published: (2024)
by: Masahiro Iijima
Published: (2024)
Multiple Sclerosis in Morocco: Impact on Patients' Quality of Life
by: Rachid Lotfi, et al.
Published: (2026)
by: Rachid Lotfi, et al.
Published: (2026)
Heterogeneity of Ocular Myasthenia Gravis: Potential Subgroups
by: Tomoko Narita, et al.
Published: (2025)
by: Tomoko Narita, et al.
Published: (2025)
Vasculitic neuropathy: Therapeutic progress and prospects
by: Michiaki Koga
Published: (2024)
by: Michiaki Koga
Published: (2024)
Effects of transcranial direct current stimulation on multiple sclerosis and neuromyelitis optica spectrum disorder: A double‐blind, randomized, crossover trial
by: Ryoko Shibuya, et al.
Published: (2025)
by: Ryoko Shibuya, et al.
Published: (2025)
Cases of AQP4 ‐Antibody‐Positive Neuromyelitis Optica Spectrum Disorder Successfully Discontinuing Steroids With Satralizumab Treatment: Considerations on the Method of Tapering for Steroids After the Introduction of Satralizumab
by: Kiyotaka Nakamagoe, et al.
Published: (2026)
by: Kiyotaka Nakamagoe, et al.
Published: (2026)
Response to: Eculizumab use throughout pregnancy in two patients with aquaporin‐4‐positive neuromyelitis optica spectrum disorder
by: Ilya Kister, et al.
Published: (2024)
by: Ilya Kister, et al.
Published: (2024)
Issue Information
Published: (2025)
Published: (2025)
Immune‐mediated spastic ataxia masquerading as clinically probable multisystem atrophy in an elderly woman
by: Rithvik Ramesh, et al.
Published: (2024)
by: Rithvik Ramesh, et al.
Published: (2024)
Development of an immunoprecipitation assay for detecting anti‐3‐hydroxy‐3‐methylglutaryl‐coenzyme A reductase autoantibodies using a non‐radioactive biotinylated recombinant protein
by: Yukihiro Nishikawa, et al.
Published: (2024)
by: Yukihiro Nishikawa, et al.
Published: (2024)
Pathogenic Roles of Age‐Associated B Cells in Neuromyelitis Optica Spectrum Disorder
by: Eiichiro Amano, et al.
Published: (2025)
by: Eiichiro Amano, et al.
Published: (2025)
Issue Information
Published: (2026)
Published: (2026)
Pathogenic Role of Age‐Associated B Cells in Autoimmune Disorders and Myasthenia Gravis
by: Hiroyuki Akamine, et al.
Published: (2025)
by: Hiroyuki Akamine, et al.
Published: (2025)
Impact of Prior Intravenous Immunoglobulin and Plasmapheresis on Eculizumab or Ravulizumab Treatment for Generalized Myasthenia Gravis: An Analysis of the MG SPOTLIGHT Registry
by: Akiyuki Uzawa, et al.
Published: (2025)
by: Akiyuki Uzawa, et al.
Published: (2025)
Recurrent Asystole Without Generalized Dysautonomia in Anti‐ NMDA Receptor Encephalitis: A Case Report
by: Tetsuya Oyama, et al.
Published: (2025)
by: Tetsuya Oyama, et al.
Published: (2025)
The Japan Neuromyelitis Optica Spectrum Disorders/Myelin Oligodendrocyte Glycoprotein Antibody‐Associated Disease Registry: Background Analysis of the Initial 116 Cases
by: Yusei Miyazaki, et al.
Published: (2025)
by: Yusei Miyazaki, et al.
Published: (2025)
Aging and Neuroimmunological Disorders
by: Takuya Matsushita
Published: (2025)
by: Takuya Matsushita
Published: (2025)
Exploring digital biomarkers using smartphones for fatigue assessment in patients with multiple sclerosis
by: Kenzo Sakurai, et al.
Published: (2024)
by: Kenzo Sakurai, et al.
Published: (2024)
Dropped head syndrome in anti‐MuSK antibody‐positive myasthenia gravis with possible concurrent axial myopathy
by: So Okubo, et al.
Published: (2024)
by: So Okubo, et al.
Published: (2024)
Human T‐cell leukemia virus type 1‐associated myelopathy/tropical spastic paraparesis and multiple sclerosis: Viral strategies and their implications
by: Makoto Nakashima, et al.
Published: (2025)
by: Makoto Nakashima, et al.
Published: (2025)
A thank you note to our reviewers
Published: (2024)
Published: (2024)
Concentration‐Dependent Increase in the Expression of Junctional Adhesion Molecule‐A in Brain Microvascular Endothelial Cells in Response to Proinflammatory Cytokines and Hyperthermic Decrease in the Expression of Vascular Endothelial Cadherin in These Cells
by: Tomohiro Matsui, et al.
Published: (2025)
by: Tomohiro Matsui, et al.
Published: (2025)
Clinical value of the Japanese version of patient‐reported multiple sclerosis neuropsychological screening questionnaire
by: Atsuya Muryoi, et al.
Published: (2025)
by: Atsuya Muryoi, et al.
Published: (2025)
Unmasking the muscle mysteries: Cutting‐edge insights into inflammatory myopathies
by: Satoshi Yamashita
Published: (2025)
by: Satoshi Yamashita
Published: (2025)
Successful treatment of multiple sclerosis with refractory rheumatoid arthritis using ofatumumab: A case report
by: Kenju Hara, et al.
Published: (2024)
by: Kenju Hara, et al.
Published: (2024)
The Past, Present, and Future of Multiple Sclerosis Clinical Research in Japan
by: Masaaki Niino
Published: (2026)
by: Masaaki Niino
Published: (2026)
Risk of progressive multifocal leukoencephalopathy in patients with multiple sclerosis treated with low‐dose natalizumab following fingolimod
by: Masami Tanaka, et al.
Published: (2024)
by: Masami Tanaka, et al.
Published: (2024)
Factors Associated With Poor Outcome Among Guillain Barre Syndrome Patients Admitted in a Tertiary Hospital in the Philippines: A Retrospective Cohort Study
by: Mario B. Prado, et al.
Published: (2026)
by: Mario B. Prado, et al.
Published: (2026)
Response to the Letter to the Editor: “Multiple Sclerosis in Morocco: Impact on Patients' Quality of Life”
by: Rachid Lotfi, et al.
Published: (2026)
by: Rachid Lotfi, et al.
Published: (2026)
Common principles of macrophage biology in blood–tissue barriers
by: Shin‐ichiro Hiraga, et al.
Published: (2024)
by: Shin‐ichiro Hiraga, et al.
Published: (2024)
Autoimmune Cerebellar Ataxia Following TNF ‐α Inhibitor Therapy for Rheumatoid Arthritis: A Case Report
by: Tomohide Ando, et al.
Published: (2026)
by: Tomohide Ando, et al.
Published: (2026)
Successful Treatment of Refractory Myelin Oligodendrocyte Glycoprotein Antibody–Associated Disease With Tocilizumab: A Case Report and Literature Review
by: Takahiko Katsuyama, et al.
Published: (2025)
by: Takahiko Katsuyama, et al.
Published: (2025)
Efficacy and Safety of Glatiramer Acetate in Japanese Multiple Sclerosis Patients
by: Akihito Hao, et al.
Published: (2025)
by: Akihito Hao, et al.
Published: (2025)
Similar Items
-
NMOSD Revisited
by: Izumi Kawachi
Published: (2025) -
NMOSD: Innate Immunology Revisited
by: Fumihiro Yanagimura, et al.
Published: (2025) -
A Case of AQP4 Antibody–Positive NMOSD Initially Manifesting as Extensive, Asymptomatic Cerebral White Matter Lesions and Subsequently Developing Cognitive Impairment
by: Takafumi Hosokawa, et al.
Published: (2025) -
Profound Cognitive Impairment as a Salient Feature of Multiple Sclerosis: A Case Report
by: Shota Ito, et al.
Published: (2026) -
Effect of Disease‐Modifying Treatments in Japanese Patients With Multiple Sclerosis During the Coronavirus Disease 2019 Pandemic
by: Taisuke Ogawa, et al.
Published: (2025)